Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: The rheumatology common toxicity criteria v.2.0

Thasia Woodworth, Daniel E. Furst, Rieke Alten, Clifton Bingham, David Yocum, Victor Sloan, Wayne Tsuji, Randall Stevens, James Fries, James Witter, Kent Johnson, Marissa Lassere, Peter Brooks

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: The rheumatology common toxicity criteria v.2.0'. Together they form a unique fingerprint.

Medicine & Life Sciences